{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:14Z","timestamp":1793387174463,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03840-9","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:34:46Z","timestamp":1753785286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4769-9610","authenticated-orcid":false,"given":"Himanshi","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-4517","authenticated-orcid":false,"given":"Jyotdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"6586","key":"3840_CR1","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, et al. Early detection of cancer. Science. 2022;375(6586):eaay9040.","journal-title":"Science"},{"issue":"1","key":"3840_CR2","doi-asserted-by":"publisher","first-page":"28131","DOI":"10.1038\/s41598-024-77658-2","volume":"14","author":"Q Guo","year":"2024","unstructured":"Guo Q, Zhu X, Beeraka NM, Zhao R, Li S, Li F, et al. Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data. Sci Rep. 2024;14(1):28131.","journal-title":"Sci Rep"},{"issue":"11","key":"3840_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.tem.2024.06.003","volume":"35","author":"J Yu","year":"2024","unstructured":"Yu J, Chen X, Yang X, Zhang B. Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment. Trends Endocrinol Metab. 2024;35(11):1006\u201320.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"3840_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut-liver axis and the intersection with the Microbiome. Nat Rev Gastroenterol Hepatol. 2018;15(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"3840_CR5","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/HEP.0000000000000406","volume":"80","author":"N Daniel","year":"2024","unstructured":"Daniel N, Genua F, Jenab M, Mayen AL, Chrysovalantou Chatziioannou A, Keski-Rahkonen P, et al. The role of the gut Microbiome in the development of hepatobiliary cancers. Hepatology. 2024;80(5):1252\u201369.","journal-title":"Hepatology"},{"key":"3840_CR6","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2147\/JHC.S485532","volume":"11","author":"LI Dolapchiev","year":"2024","unstructured":"Dolapchiev LI, Gonzales KA, Cruz LR, Gagea M, Stevenson HL, Kwan SY, et al. Gut Microbiome and hepatic transcriptomic determinants of HCC development in mice with metabolic Dysfunction-Associated steatohepatitis. J Hepatocell Carcinoma. 2024;11:1891\u2013905.","journal-title":"J Hepatocell Carcinoma"},{"issue":"7516","key":"3840_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, et al. Alterations of the human gut Microbiome in liver cirrhosis. Nature. 2014;513(7516):59\u201364.","journal-title":"Nature"},{"issue":"1","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","volume":"12","author":"J Behary","year":"2021","unstructured":"Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, et al. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nat Commun. 2021;12(1):187.","journal-title":"Nat Commun"},{"issue":"7","key":"3840_CR9","first-page":"3605","volume":"24","author":"N Jiang","year":"2020","unstructured":"Jiang N, Song X, Peng YM, Wang WN, Song Z. Association of disease condition with changes in intestinal flora, and plasma endotoxin and vascular endothelial growth factor levels in patients with liver cancer. Eur Rev Med Pharmacol Sci. 2020;24(7):3605\u201313.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3840_CR10","doi-asserted-by":"crossref","unstructured":"Feng J, Wu Y, Dai P, Wang D, Liu L, Chai B. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives. J Appl Microbiol. 2023;134(10).","DOI":"10.1093\/jambio\/lxad221"},{"key":"3840_CR11","doi-asserted-by":"crossref","unstructured":"Xu W, Jiang Y, Tao J, Liu Y, Xia Y, Chen C et al. Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of coriobacterium, atopobium, Coprococcus and Veillonella dispar May be a new method for HCC diagnosis. J Med Microbiol. 2023;72(6).","DOI":"10.1099\/jmm.0.001713"},{"issue":"1","key":"3840_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-022-01015-3","volume":"8","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, Liu W, Pan L, Bao Y, Yan Z, Hong L. Overabundance of Veillonella parvula promotes intestinal inflammation by activating macrophages via LPS-TLR4 pathway. Cell Death Discov. 2022;8(1):251.","journal-title":"Cell Death Discov"},{"issue":"12","key":"3840_CR13","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/CVI.00310-09","volume":"16","author":"G Matera","year":"2009","unstructured":"Matera G, Muto V, Vinci M, Zicca E, Abdollahi-Roodsaz S, van de Veerdonk FL, et al. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol. 2009;16(12):1804\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"3840_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00018-023-05055-5","volume":"81","author":"Y Jin","year":"2024","unstructured":"Jin Y, Shi M, Feng J, Zhang Z, Zhao B, Li Q, et al. Splenectomy ameliorates liver cirrhosis by restoring the gut microbiota balance. Cell Mol Life Sci. 2024;81(1):32.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s00431-023-05411-4","volume":"183","author":"J Thestrup","year":"2024","unstructured":"Thestrup J, Sorensen JL, Hybschmann J, Topperzer MK, Graber K, O\u2019Farrelly C, et al. Establishing consensus on principles and competencies for the use of play in clinical practice in hospitals: an international Delphi study. Eur J Pediatr. 2024;183(4):1595\u2013605.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"3840_CR16","doi-asserted-by":"publisher","first-page":"101056","DOI":"10.1016\/j.jhepr.2024.101056","volume":"6","author":"B Moeckli","year":"2024","unstructured":"Moeckli B, Delaune V, Gilbert B, Peloso A, Oldani G, El Hajji S, et al. Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut Microbiome. JHEP Rep. 2024;6(5):101056.","journal-title":"JHEP Rep"},{"issue":"22","key":"3840_CR17","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3840_CR18","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s12276-023-01054-5","volume":"55","author":"JH Shin","year":"2023","unstructured":"Shin JH, Bozadjieva-Kramer N, Seeley RJ. Reg3gamma: current Understanding and future therapeutic opportunities in metabolic disease. Exp Mol Med. 2023;55(8):1672\u20137.","journal-title":"Exp Mol Med"},{"issue":"4","key":"3840_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/mi.2013.109","volume":"7","author":"LM Loonen","year":"2014","unstructured":"Loonen LM, Stolte EH, Jaklofsky MT, Meijerink M, Dekker J, van Baarlen P, et al. REG3gamma-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol. 2014;7(4):939\u201347.","journal-title":"Mucosal Immunol"},{"key":"3840_CR20","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol. 2023;14:1161067.","journal-title":"Front Immunol"},{"issue":"3","key":"3840_CR21","doi-asserted-by":"publisher","first-page":"e0173004","DOI":"10.1371\/journal.pone.0173004","volume":"12","author":"N Ottman","year":"2017","unstructured":"Ottman N, Reunanen J, Meijerink M, Pietila TE, Kainulainen V, Klievink J, et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. PLoS ONE. 2017;12(3):e0173004.","journal-title":"PLoS ONE"},{"issue":"1","key":"3840_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","volume":"23","author":"H Plovier","year":"2017","unstructured":"Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107\u201313.","journal-title":"Nat Med"},{"issue":"2","key":"3840_CR23","doi-asserted-by":"publisher","first-page":"e0340322","DOI":"10.1128\/spectrum.03403-22","volume":"11","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liang Y, Jiang J, Lu C, Shi F, Cao Q, et al. A High-Salt diet exacerbates liver fibrosis through Enterococcus-Dependent macrophage activation. Microbiol Spectr. 2023;11(2):e0340322.","journal-title":"Microbiol Spectr"},{"issue":"10","key":"3840_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s43018-021-00251-3","volume":"2","author":"N Iida","year":"2021","unstructured":"Iida N, Mizukoshi E, Yamashita T, Yutani M, Seishima J, Wang Z, et al. Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nat Cancer. 2021;2(10):1039\u201354.","journal-title":"Nat Cancer"},{"issue":"7783","key":"3840_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505\u201311.","journal-title":"Nature"},{"issue":"7285","key":"3840_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59\u201365.","journal-title":"Nature"},{"issue":"1","key":"3840_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-023-03940-y","volume":"21","author":"L Zhang","year":"2023","unstructured":"Zhang L, Chen C, Chai D, Li C, Qiu Z, Kuang T, et al. Characterization of the intestinal fungal Microbiome in patients with hepatocellular carcinoma. J Transl Med. 2023;21(1):126.","journal-title":"J Transl Med"},{"key":"3840_CR28","doi-asserted-by":"publisher","first-page":"812771","DOI":"10.3389\/fmicb.2022.812771","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li Y, Li C, Lei G, Zhou L, Chen X, et al. Intestinal Candida albicans promotes hepatocarcinogenesis by Up-Regulating NLRP6. Front Microbiol. 2022;13:812771.","journal-title":"Front Microbiol"},{"issue":"6","key":"3840_CR29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s11427-023-2458-1","volume":"67","author":"S Jiang","year":"2024","unstructured":"Jiang S, Xu L, Chen Y, Shu Z, Lv L, Zhao Y, et al. Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease. Sci China Life Sci. 2024;67(6):1183\u201398.","journal-title":"Sci China Life Sci"},{"key":"3840_CR30","doi-asserted-by":"publisher","first-page":"101495","DOI":"10.1016\/j.redox.2020.101495","volume":"32","author":"N Wang","year":"2020","unstructured":"Wang N, Liu H, Liu G, Li M, He X, Yin C, et al. Yeast beta-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis. Redox Biol. 2020;32:101495.","journal-title":"Redox Biol"},{"issue":"1","key":"3840_CR31","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1038\/s41598-020-59535-w","volume":"10","author":"TS Dong","year":"2020","unstructured":"Dong TS, Katzka W, Lagishetty V, Luu K, Hauer M, Pisegna J, et al. A microbial signature identifies advanced fibrosis in patients with chronic liver disease mainly due to NAFLD. Sci Rep. 2020;10(1):2771.","journal-title":"Sci Rep"},{"issue":"5","key":"3840_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, et al. A universal Gut-Microbiome-Derived signature predicts cirrhosis. Cell Metab. 2020;32(5):878\u201388. e6.","journal-title":"Cell Metab"},{"issue":"4","key":"3840_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","volume":"157","author":"JB Schwimmer","year":"2019","unstructured":"Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, et al. Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease. Gastroenterology. 2019;157(4):1109\u201322.","journal-title":"Gastroenterology"},{"issue":"1","key":"3840_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cld.2017.08.009","volume":"22","author":"P Puri","year":"2018","unstructured":"Puri P, Sanyal AJ. The intestinal Microbiome in nonalcoholic fatty liver disease. Clin Liver Dis. 2018;22(1):121\u201332.","journal-title":"Clin Liver Dis"},{"issue":"9","key":"3840_CR35","doi-asserted-by":"publisher","first-page":"e0043424","DOI":"10.1128\/msystems.00434-24","volume":"9","author":"SY Kwan","year":"2024","unstructured":"Kwan SY, Sabotta CM, Cruz LR, Wong MC, Ajami NJ, McCormick JB, et al. Gut phageome in Mexican americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes. mSystems. 2024;9(9):e0043424.","journal-title":"mSystems"},{"issue":"5","key":"3840_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jgh.16147","volume":"38","author":"S Moran-Ramos","year":"2023","unstructured":"Moran-Ramos S, Cerqueda-Garcia D, Lopez-Contreras B, Larrieta-Carrasco E, Villamil-Ramirez H, Molina-Cruz S, et al. A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesity. J Gastroenterol Hepatol. 2023;38(5):791\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"3840_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13099-022-00482-4","volume":"14","author":"M Naseri","year":"2022","unstructured":"Naseri M, Palizban F, Yadegar A, Khodarahmi M, Asadzadeh Aghdaei H, Houri H, et al. Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies. Gut Pathog. 2022;14(1):9.","journal-title":"Gut Pathog"},{"issue":"4","key":"3840_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/gutjnl-2022-328403","volume":"72","author":"JS Bajaj","year":"2023","unstructured":"Bajaj JS, Pena-Rodriguez M, La Reau A, Phillips W, Fuchs M, Davis BC, et al. Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosis. Gut. 2023;72(4):759\u201371.","journal-title":"Gut"},{"issue":"11","key":"3840_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21(11):719\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"3840_CR40","doi-asserted-by":"crossref","unstructured":"Zhang F, Gia A, Chen G, Gong L, Behary J, Hold GL et al. Critical assessment of whole genome and viral enrichment shotgun metagenome on the characterization of stool total Virome in hepatocellular carcinoma patients. Viruses. 2022;15(1).","DOI":"10.3390\/v15010053"},{"issue":"4","key":"3840_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70(4):761\u201374.","journal-title":"Gut"},{"issue":"4","key":"3840_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21(4):236\u201347.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"3840_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in Gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3840_CR44","doi-asserted-by":"crossref","unstructured":"Xing L, Zhang Y, Li S, Tong M, Bi K, Zhang Q et al. A dual coverage monitoring of the bile acids profile in the Liver-Gut Axis throughout the whole Inflammation-Cancer transformation progressive: reveal hepatocellular carcinoma pathogenesis. Int J Mol Sci. 2023;24(5).","DOI":"10.3390\/ijms24054258"},{"issue":"3","key":"3840_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2018.09.004","volume":"175","author":"V Singh","year":"2018","unstructured":"Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, et al. Dysregulated microbial fermentation of soluble Fiber induces cholestatic liver Cancer. Cell. 2018;175(3):679\u201394. e22.","journal-title":"Cell"},{"issue":"7","key":"3840_CR46","doi-asserted-by":"publisher","first-page":"101042831771210","DOI":"10.1177\/1010428317712102","volume":"39","author":"H Yu","year":"2017","unstructured":"Yu H, Zhang X, Liu R, Li H, Xiao X, Zhou Y, et al. Mcl-1 suppresses Abasic site repair following bile acid-induced hepatic cellular DNA damage. Tumour Biol. 2017;39(7):1010428317712102.","journal-title":"Tumour Biol"},{"issue":"3","key":"3840_CR47","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","volume":"11","author":"S Sydor","year":"2020","unstructured":"Sydor S, Best J, Messerschmidt I, Manka P, Vilchez-Vargas R, Brodesser S, et al. Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin Transl Gastroenterol. 2020;11(3):e00131.","journal-title":"Clin Transl Gastroenterol"},{"key":"3840_CR48","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Reddy KR, O\u2019Leary JG, Vargas HE, Lai JC, Kamath PS et al. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology. 2020;159(5):1715-30 e12.","DOI":"10.1053\/j.gastro.2020.07.019"},{"issue":"5","key":"3840_CR49","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, et al. Gut microbiota promotes Obesity-Associated liver Cancer through PGE(2)-Mediated suppression of antitumor immunity. Cancer Discov. 2017;7(5):522\u201338.","journal-title":"Cancer Discov"},{"issue":"3","key":"3840_CR50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2337\/dbi16-0066","volume":"66","author":"SL Shyng","year":"2017","unstructured":"Shyng SL. Targeting the gut Microbiota-FXR signaling Axis for glycemic control: does a dietary supplement work magic?? Diabetes. 2017;66(3):571\u20133.","journal-title":"Diabetes"},{"issue":"4","key":"3840_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4983","volume":"243","author":"L Sheng","year":"2017","unstructured":"Sheng L, Jena PK, Hu Y, Liu HX, Nagar N, Kalanetra KM, et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J Pathol. 2017;243(4):431\u201341.","journal-title":"J Pathol"},{"issue":"1","key":"3840_CR52","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41598-017-01576-9","volume":"7","author":"L Sheng","year":"2017","unstructured":"Sheng L, Jena PK, Liu HX, Kalanetra KM, Gonzalez FJ, French SW, et al. Gender differences in bile acids and microbiota in relationship with gender dissimilarity in steatosis induced by diet and FXR inactivation. Sci Rep. 2017;7(1):1748.","journal-title":"Sci Rep"},{"issue":"1","key":"3840_CR53","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/jpet.111.179390","volume":"338","author":"A Wolfe","year":"2011","unstructured":"Wolfe A, Thomas A, Edwards G, Jaseja R, Guo GL, Apte U. Increased activation of the Wnt\/beta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J Pharmacol Exp Ther. 2011;338(1):12\u201321.","journal-title":"J Pharmacol Exp Ther"},{"key":"3840_CR54","doi-asserted-by":"publisher","first-page":"840171","DOI":"10.3389\/fcell.2022.840171","volume":"10","author":"Y Wu","year":"2022","unstructured":"Wu Y, Rong X, Pan M, Wang T, Yang H, Chen X, et al. Integrated analysis reveals the gut microbial metabolite TMAO promotes inflammatory hepatocellular carcinoma by upregulating POSTN. Front Cell Dev Biol. 2022;10:840171.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"3840_CR55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1101\/gad.201731.112","volume":"27","author":"W Zhang","year":"2013","unstructured":"Zhang W, Hietakangas V, Wee S, Lim SC, Gunaratne J, Cohen SM. ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation. Genes Dev. 2013;27(4):441\u20139.","journal-title":"Genes Dev"},{"issue":"6","key":"3840_CR56","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cmet.2019.08.021","volume":"30","author":"S Chen","year":"2019","unstructured":"Chen S, Henderson A, Petriello MC, Romano KA, Gearing M, Miao J, et al. Trimethylamine N-Oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab. 2019;30(6):1141\u201351. e5.","journal-title":"Cell Metab"},{"key":"3840_CR57","doi-asserted-by":"crossref","unstructured":"Lee S, Usman TO, Yamauchi J, Chhetri G, Wang X, Coudriet GM et al. Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis. J Clin Invest. 2022;132(14).","DOI":"10.1172\/JCI154333"},{"issue":"6","key":"3840_CR58","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase Inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3840_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41598-018-36941-9","volume":"9","author":"S Chriett","year":"2019","unstructured":"Chriett S, Dabek A, Wojtala M, Vidal H, Balcerczyk A, Pirola L. Prominent action of butyrate over beta-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. Sci Rep. 2019;9(1):742.","journal-title":"Sci Rep"},{"key":"3840_CR60","doi-asserted-by":"publisher","first-page":"105059","DOI":"10.1016\/j.phrs.2020.105059","volume":"160","author":"Q Gao","year":"2020","unstructured":"Gao Q, Wei A, Chen F, Chen X, Ding W, Ding Z, et al. Enhancing PPARgamma by HDAC Inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice. Pharmacol Res. 2020;160:105059.","journal-title":"Pharmacol Res"},{"issue":"29","key":"3840_CR61","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1021\/acs.jafc.8b01189","volume":"66","author":"B Sun","year":"2018","unstructured":"Sun B, Jia Y, Hong J, Sun Q, Gao S, Hu Y, et al. Sodium butyrate ameliorates High-Fat-Diet-Induced Non-alcoholic fatty liver disease through peroxisome Proliferator-Activated receptor alpha-Mediated activation of beta oxidation and suppression of inflammation. J Agric Food Chem. 2018;66(29):7633\u201342.","journal-title":"J Agric Food Chem"},{"issue":"8","key":"3840_CR62","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/bjc.2012.409","volume":"107","author":"LB Bindels","year":"2012","unstructured":"Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer. 2012;107(8):1337\u201344.","journal-title":"Br J Cancer"},{"issue":"9","key":"3840_CR63","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/1940-6207.CAPR-11-0364","volume":"5","author":"Y Lin","year":"2012","unstructured":"Lin Y, Yu LX, Yan HX, Yang W, Tang L, Zhang HL, et al. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4. Cancer Prev Res (Phila). 2012;5(9):1090\u2013102.","journal-title":"Cancer Prev Res (Phila)"},{"key":"3840_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1741-7015-10-98","volume":"10","author":"YY Jing","year":"2012","unstructured":"Jing YY, Han ZP, Sun K, Zhang SS, Hou J, Liu Y, et al. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med. 2012;10:98.","journal-title":"BMC Med"},{"issue":"10","key":"3840_CR65","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.1007\/s13277-014-2347-5","volume":"35","author":"H Li","year":"2014","unstructured":"Li H, Li Y, Liu D, Liu J. LPS promotes epithelial-mesenchymal transition and activation of TLR4\/JNK signaling. Tumour Biol. 2014;35(10):10429\u201335.","journal-title":"Tumour Biol"},{"key":"3840_CR66","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, Wang Z, Ding Y, Qin Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308.","journal-title":"Front Immunol"},{"key":"3840_CR67","doi-asserted-by":"crossref","unstructured":"Liu B, Zhou Z, Jin Y, Lu J, Feng D, Peng R et al. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma. J Immunother Cancer. 2022;10(1).","DOI":"10.1136\/jitc-2021-003069"},{"key":"3840_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","volume":"117","author":"S Lopes-Paciencia","year":"2019","unstructured":"Lopes-Paciencia S, Saint-Germain E, Rowell MC, Ruiz AF, Kalegari P, Ferbeyre G. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15\u201322.","journal-title":"Cytokine"},{"issue":"7456","key":"3840_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97\u2013101.","journal-title":"Nature"},{"issue":"1","key":"3840_CR70","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12967-023-03938-6","volume":"21","author":"Y He","year":"2023","unstructured":"He Y, Zhang Q, Yu X, Zhang S, Guo W. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues. J Transl Med. 2023;21(1):68.","journal-title":"J Transl Med"},{"issue":"4","key":"3840_CR71","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4103\/jcrt.jcrt_139_22","volume":"19","author":"P Sun","year":"2023","unstructured":"Sun P, Li Z, Zhang B. Characterization of disease-associated microbiota in hepatocellular carcinoma. J Cancer Res Ther. 2023;19(4):881\u201391.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"3840_CR72","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1002\/ctm2.1331","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun L, Ke X, Guan A, Jin B, Qu J, Wang Y, et al. Intratumoural Microbiome can predict the prognosis of hepatocellular carcinoma after surgery. Clin Transl Med. 2023;13(7):e1331.","journal-title":"Clin Transl Med"},{"issue":"7","key":"3840_CR73","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep4.1908","volume":"6","author":"D Qu","year":"2022","unstructured":"Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral Microbiome of human primary liver Cancer. Hepatol Commun. 2022;6(7):1741\u201352.","journal-title":"Hepatol Commun"},{"issue":"4","key":"3840_CR74","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/HEP.0000000000000427","volume":"78","author":"S Li","year":"2023","unstructured":"Li S, Xia H, Wang Z, Zhang X, Song T, Li J, et al. Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC. Hepatology. 2023;78(4):1079\u201391.","journal-title":"Hepatology"},{"key":"3840_CR75","doi-asserted-by":"crossref","unstructured":"Xu J, Zhan Q, Fan Y, Lo EKK, Zhang F, Yu Y et al. Clinical aspects of gut microbiota in hepatocellular carcinoma management. Pathogens. 2021;10(7).","DOI":"10.3390\/pathogens10070782"},{"key":"3840_CR76","doi-asserted-by":"crossref","unstructured":"Gok Yavuz B, Datar S, Chamseddine S, Mohamed YI, LaPelusa M, Lee SS et al. The gut Microbiome as a biomarker and therapeutic target in hepatocellular carcinoma. Cancers (Basel). 2023;15(19).","DOI":"10.3390\/cancers15194875"},{"issue":"5","key":"3840_CR77","doi-asserted-by":"publisher","first-page":"947","DOI":"10.4251\/wjgo.v14.i5.947","volume":"14","author":"I Said","year":"2022","unstructured":"Said I, Ahad H, Said A. Gut Microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: current knowledge and potential for therapeutics. World J Gastrointest Oncol. 2022;14(5):947\u201358.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"3840_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12967-024-05036-7","volume":"22","author":"C Xue","year":"2024","unstructured":"Xue C, Gu X, Shi Q, Ma X, Jia J, Su Y, et al. The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma. J Transl Med. 2024;22(1):237.","journal-title":"J Transl Med"},{"issue":"9","key":"3840_CR79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"LX Yu","year":"2017","unstructured":"Yu LX, Schwabe RF. The gut Microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14(9):527\u201339.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3840_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina VB, Tyakht AV, Odintsova VY, Yarygin KS, Kovarsky BA, Pavlenko AV, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome. 2017;5(1):141.","journal-title":"Microbiome"},{"issue":"8","key":"3840_CR81","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA Kirpich","year":"2008","unstructured":"Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol. 2008;42(8):675\u201382.","journal-title":"Alcohol"},{"issue":"1","key":"3840_CR82","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12866-016-0848-7","volume":"16","author":"C Rodriguez","year":"2016","unstructured":"Rodriguez C, Taminiau B, Korsak N, Avesani V, Van Broeck J, Brach P, et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol. 2016;16(1):229.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3840_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.27927","volume":"63","author":"JH Tabibian","year":"2016","unstructured":"Tabibian JH, O\u2019Hara SP, Trussoni CE, Tietz PS, Splinter PL, Mounajjed T, et al. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis. Hepatology. 2016;63(1):185\u201396.","journal-title":"Hepatology"},{"issue":"2","key":"3840_CR84","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54(2):562\u201372.","journal-title":"Hepatology"},{"issue":"6","key":"3840_CR85","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, et al. Colonic mucosal Microbiome differs from stool Microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 2012;303(6):G675\u201385.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3840_CR86","doi-asserted-by":"publisher","first-page":"869250","DOI":"10.3389\/fmicb.2022.869250","volume":"13","author":"J Kim","year":"2022","unstructured":"Kim J, Ahn SW, Kim JY, Whon TW, Lim SK, Ryu BH, et al. Probiotic lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration. Front Microbiol. 2022;13:869250.","journal-title":"Front Microbiol"},{"issue":"4","key":"3840_CR87","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504\u201316.","journal-title":"Cancer Cell"},{"issue":"1","key":"3840_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2017.08.109","volume":"493","author":"Y Song","year":"2017","unstructured":"Song Y, Yang JM. Role of Interleukin (IL)-17 and T-helper (Th)17 cells in cancer. Biochem Biophys Res Commun. 2017;493(1):1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3840_CR89","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17(2):225\u201335.","journal-title":"Cell Metab"},{"issue":"43","key":"3840_CR90","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.3748\/wjg.v27.i43.7402","volume":"27","author":"J Gubatan","year":"2021","unstructured":"Gubatan J, Holman DR, Puntasecca CJ, Polevoi D, Rubin SJ, Rogalla S. Antimicrobial peptides and the gut Microbiome in inflammatory bowel disease. World J Gastroenterol. 2021;27(43):7402\u201322.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3840_CR91","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/hepr.13473","volume":"50","author":"JP Arab","year":"2020","unstructured":"Arab JP, Arrese M, Shah VH. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: current concepts and perspectives. Hepatol Res. 2020;50(4):407\u201318.","journal-title":"Hepatol Res"},{"issue":"3","key":"3840_CR92","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","volume":"30","author":"R Loomba","year":"2019","unstructured":"Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, et al. Gut Microbiome-Based metagenomic signature for Non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2019;30(3):607.","journal-title":"Cell Metab"},{"issue":"6","key":"3840_CR93","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al. Gut Microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019;68(6):1014\u201323.","journal-title":"Gut"},{"key":"3840_CR94","doi-asserted-by":"publisher","first-page":"1152987","DOI":"10.3389\/fcimb.2023.1152987","volume":"13","author":"F Yan","year":"2023","unstructured":"Yan F, Zhang Q, Shi K, Zhang Y, Zhu B, Bi Y, et al. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Front Cell Infect Microbiol. 2023;13:1152987.","journal-title":"Front Cell Infect Microbiol"},{"key":"3840_CR95","doi-asserted-by":"crossref","unstructured":"Gupta H, Min BH, Ganesan R, Gebru YA, Sharma SP, Park E et al. Gut Microbiome in Non-Alcoholic fatty liver disease: from mechanisms to therapeutic role. Biomedicines. 2022;10(3).","DOI":"10.3390\/biomedicines10030550"},{"issue":"43","key":"3840_CR96","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.3748\/wjg.v27.i43.7446","volume":"27","author":"MA Neag","year":"2021","unstructured":"Neag MA, Mitre AO, Catinean A, Buzoianu AD. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World J Gastroenterol. 2021;27(43):7446\u201361.","journal-title":"World J Gastroenterol"},{"key":"3840_CR97","doi-asserted-by":"crossref","unstructured":"Scarpellini E, Scarlata GGM, Santori V, Scarcella M, Kobyliak N, Abenavoli L. Gut microbiota, deranged immunity, and hepatocellular carcinoma. Biomedicines. 2024;12(8).","DOI":"10.3390\/biomedicines12081797"},{"issue":"2","key":"3840_CR98","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.hbpd.2020.01.003","volume":"19","author":"BC Rao","year":"2020","unstructured":"Rao BC, Lou JM, Wang WJ, Li A, Cui GY, Yu ZJ, et al. Human Microbiome is a diagnostic biomarker in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2020;19(2):109\u201315.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"3840_CR99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/jci.insight.94416","volume":"2","author":"C Acharya","year":"2017","unstructured":"Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight. 2017;2:19.","journal-title":"JCI Insight"},{"issue":"1","key":"3840_CR100","doi-asserted-by":"publisher","first-page":"2201159","DOI":"10.1080\/19490976.2023.2201159","volume":"15","author":"J Yang","year":"2023","unstructured":"Yang J, He Q, Lu F, Chen K, Ni Z, Wang H, et al. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma. Gut Microbes. 2023;15(1):2201159.","journal-title":"Gut Microbes"},{"issue":"6","key":"3840_CR101","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41416-024-02582-1","volume":"130","author":"EJ Cho","year":"2024","unstructured":"Cho EJ, Kim B, Yu SJ, Hong SK, Choi Y, Yi NJ, et al. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma. Br J Cancer. 2024;130(6):970\u20135.","journal-title":"Br J Cancer"},{"issue":"6","key":"3840_CR102","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol. 2023;79(6):1352\u201365.","journal-title":"J Hepatol"},{"issue":"4","key":"3840_CR103","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.23845","volume":"52","author":"LX Yu","year":"2010","unstructured":"Yu LX, Yan HX, Liu Q, Yang W, Wu HP, Dong W, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology. 2010;52(4):1322\u201333.","journal-title":"Hepatology"},{"issue":"6264","key":"3840_CR104","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084\u20139.","journal-title":"Science"},{"issue":"6371","key":"3840_CR105","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, et al. Gut Microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"1","key":"3840_CR106","doi-asserted-by":"publisher","first-page":"e3639","DOI":"10.1002\/jgm.3639","volume":"26","author":"X Lan","year":"2024","unstructured":"Lan X, Ma J, Huang Z, Xu Y, Hu Y. Akkermansia muciniphila might improve anti-PD-1 therapy against HCC by changing host bile acid metabolism. J Gene Med. 2024;26(1):e3639.","journal-title":"J Gene Med"},{"issue":"1","key":"3840_CR107","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.xcrm.2024.101900","volume":"6","author":"XQ Wu","year":"2025","unstructured":"Wu XQ, Ying F, Chung KPS, Leung CON, Leung RWH, So KKH, et al. Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma. Cell Rep Med. 2025;6(1):101900.","journal-title":"Cell Rep Med"},{"key":"3840_CR108","doi-asserted-by":"crossref","unstructured":"Lee PC, Wu CJ, Hung YW, Lee CJ, Chi CT, Lee IC et al. Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma. J Immunother Cancer. 2022;10(6).","DOI":"10.1136\/jitc-2022-004779"},{"issue":"1","key":"3840_CR109","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40425-019-0650-9","volume":"7","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang T, Tu X, Huang Y, Zhang H, Tan D, et al. Gut Microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. J Immunother Cancer. 2019;7(1):193.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3840_CR110","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13059-015-0759-1","volume":"16","author":"R Blekhman","year":"2015","unstructured":"Blekhman R, Goodrich JK, Huang K, Sun Q, Bukowski R, Bell JT, et al. Host genetic variation impacts Microbiome composition across human body sites. Genome Biol. 2015;16(1):191.","journal-title":"Genome Biol"},{"issue":"9","key":"3840_CR111","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.it.2017.06.003","volume":"38","author":"A Kurilshikov","year":"2017","unstructured":"Kurilshikov A, Wijmenga C, Fu J, Zhernakova A. Host genetics and gut microbiome: challenges and perspectives. Trends Immunol. 2017;38(9):633\u201347.","journal-title":"Trends Immunol"},{"issue":"4","key":"3840_CR112","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrm3314","volume":"13","author":"GJ Patti","year":"2012","unstructured":"Patti GJ, Yanes O, Siuzdak G, Innovation. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263\u20139.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"3840_CR113","doi-asserted-by":"publisher","first-page":"e1800363","DOI":"10.1002\/pmic.201800363","volume":"19","author":"DL Peters","year":"2019","unstructured":"Peters DL, Wang W, Zhang X, Ning Z, Mayne J, Figeys D. Metaproteomic and metabolomic approaches for characterizing the gut Microbiome. Proteomics. 2019;19(16):e1800363.","journal-title":"Proteomics"},{"issue":"1","key":"3840_CR114","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41597-019-0202-7","volume":"6","author":"D Gomez-Cabrero","year":"2019","unstructured":"Gomez-Cabrero D, Tarazona S, Ferreiros-Vidal I, Ramirez RN, Company C, Schmidt A, et al. STATegra, a comprehensive multi-omics dataset of B-cell differentiation in mouse. Sci Data. 2019;6(1):256.","journal-title":"Sci Data"},{"key":"3840_CR115","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3389\/fmicb.2017.02224","volume":"8","author":"GB Gloor","year":"2017","unstructured":"Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017;8:2224.","journal-title":"Front Microbiol"},{"key":"3840_CR116","doi-asserted-by":"crossref","unstructured":"Lutz KC, Jiang S, Neugent ML, De Nisco NJ, Zhan X, Li Q. A survey of statistical methods for Microbiome data analysis. Front Appl Math Stat. 2022;8.","DOI":"10.3389\/fams.2022.884810"},{"issue":"2","key":"3840_CR117","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","volume":"7","author":"RH Mills","year":"2022","unstructured":"Mills RH, Dulai PS, Vazquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, et al. Multi-omics analyses of the ulcerative colitis gut Microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol. 2022;7(2):262\u201376.","journal-title":"Nat Microbiol"},{"issue":"2","key":"3840_CR118","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13167-018-0132-z","volume":"9","author":"RV Bubnov","year":"2018","unstructured":"Bubnov RV, Babenko LP, Lazarenko LM, Mokrozub VV, Spivak MY. Specific properties of probiotic strains: relevance and benefits for the host. EPMA J. 2018;9(2):205\u201323.","journal-title":"EPMA J"},{"key":"3840_CR119","doi-asserted-by":"crossref","unstructured":"Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of probiotics on gut microbiota: an overview. Int J Mol Sci. 2024;25(11).","DOI":"10.3390\/ijms25116022"},{"key":"3840_CR120","doi-asserted-by":"publisher","first-page":"609722","DOI":"10.3389\/fcimb.2021.609722","volume":"11","author":"S Han","year":"2021","unstructured":"Han S, Lu Y, Xie J, Fei Y, Zheng G, Wang Z, et al. Probiotic Gastrointestinal transit and colonization after oral administration: A long journey. Front Cell Infect Microbiol. 2021;11:609722.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03840-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:47:09Z","timestamp":1757321229000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03840-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03840-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical committee approval was not required for this work as it did not involve human subjects or animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}